Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
-
Watsco Declares $3.30 Quarterly Dividend
-
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
-
Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
-
Helus Pharma Announces Completion of Legal Name Change
-
Streamex CEO Henry McPhie to Embark on Asia Tour with Events in Singapore and Hong Kong
-
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
-
Habit Is Giving Away Alex Vesia Bobbleheads. Yes, He’s Holding His Double Play Char
-
FTI Consulting Appoints Christina Morris as a Senior Managing Director to Expand AI-Enabled Healthcare Capabilities
-
One Bullion Completes Second Hole of 2026 Drilling Program at Vumba Gold Project
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Form 8.5 (EPT/RI)-SThree Plc
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Dubai Born LavishCars goes International led by founder Bilawal Merani
-
Big Bear Gold Corp. Signs Assignment and Assumption of Property Option Agreement to Acquire 100% Optioned Interest in Peerless Property
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Organic Remedies Launches Annual Breast Cancer Awareness Campaign
-
Edible Garden Purchases a 6.2 Acre Building in Webster City, Iowa to Develop 100+ Million Unit Ready-to-Drink Manufacturing Platform
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Mee
-
Unicycive Therapeutics Appoints Meredith Manning to Board of Directors
-
Lantronix Secures Blue UAS Companion Computer SOM Listing, Expanding Defense Drone Opportunity
-
OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course
-
Calian completes sale of U.S. commercial IT business to Trace3
-
Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 30 09 2026 - (CGWL)
-
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
-
Anfield Energy Receives Positive Colorado DRMS Decision Completing State Review of JD-8 Uranium-Vanadium Mine
-
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
-
Payments Canada welcomes six new members as expanded membership eligibility reaches one-year milestone
-
Myhal Family Foundation pledges $1 million matching gift to help Ukrainians prepare for another winter
-
One of the most remote infrastructure projects in the US takes shape in Alaska
-
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
-
Fairtrade Month Launches on a Historic High: Canadian Sales Generate $10 Million for Farmers Worldwide
-
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
-
Yukon Metals Intersects 23.5 Metres of 0.48 G/T Gold and 0.11% Copper Near Surface, Extending Birch Skarn System to Approximately 1 Kilometre of Drilled Strike
-
Controlled Thermal Resources and Plum Acquisition Corp. IV Announce Strengthened Capital Structure to Advance Hell’s Kitchen Geothermal Power and Critical Minerals Project
-
Origin Agritech Strengthens Liquidity by Selling Its Xinjiang Seed Subsidiary and Leasing Back the Production Base
-
USA Rare Earth Completes CEO Transition
-
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
-
Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
-
Fervo Energy Declares Commercial Operation at Cape Station Ahead of Schedule, Leading the Race for Next-Generation Geothermal Energy
-
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
-
Amplify ETFs Highlights HACK and HAKY During Cybersecurity Awareness Month
-
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
-
Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
-
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
-
PyroGenesis Confirms Completion of Installation of 4.5 MW Plasma Torch System at U.S. Defense and Aeronautics Research Facility
-
Oceanic Iron Ore Corp. Begins Trading on OTCQX Best Market
-
Homes for Heroes Names Amit Kulkarni CEO
-
MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting
